AI assistant
Sending…
STEPAN CO — Director's Dealing 2017
Sep 12, 2017
32175_dirs_2017-09-12_4af445e1-8839-41c3-a50e-87dbd44f1eb0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEPAN CO (SCL)
CIK: 0000094049
Period of Report: 2017-09-08
Reporting Person: PACHOLEC FRANK (Vice President R&D)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-08 | Common Stock | M | 500 | $25.605 | Acquired | 49014 | Direct |
| 2017-09-08 | Common Stock | S | 500 | $79.60 | Disposed | 48514 | Direct |
| 2017-09-11 | Common Stock | M | 1000 | $25.605 | Acquired | 49514 | Direct |
| 2017-09-11 | Common Stock | S | 1000 | $80.35 | Disposed | 48514 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-08 | Employee Stock Option (Right to Buy) | $25.605 | M | 500 | Disposed | 2018-02-08 | Common Stock (500) | Direct |
| 2017-09-11 | Employee Stock Option (Right to Buy) | $25.605 | M | 1000 | Disposed | 2018-02-08 | Common Stock (1000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2048.479 | Indirect |
Footnotes
F1: Transaction completed pursuant to a 10b5-1 trading plan.
F2: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $80.10 to $80.60, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer.
More from STEPAN CO
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 23
Regulatory Filings
2026
Feb 23
Director's Dealing
2026
Feb 19